SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-030126
Filing Date
2014-05-14
Accepted
2014-05-14 07:01:24
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v377860_10q.htm 10-Q 448100
2 EXHIBIT 31.1 v377860_ex31-1.htm EX-31.1 12337
3 EXHIBIT 31.2 v377860_ex31-2.htm EX-31.2 12260
4 EXHIBIT 32.1 v377860_ex32-1.htm EX-32.1 4780
5 EXHIBIT 32.2 v377860_ex32-2.htm EX-32.2 4894
  Complete submission text file 0001144204-14-030126.txt   5861172

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aker-20140331.xml EX-101.INS 961422
7 XBRL TAXONOMY EXTENSION SCHEMA aker-20140331.xsd EX-101.SCH 54996
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aker-20140331_cal.xml EX-101.CAL 44639
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aker-20140331_def.xml EX-101.DEF 244861
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aker-20140331_lab.xml EX-101.LAB 331281
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aker-20140331_pre.xml EX-101.PRE 314786
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 14839177
SIC: 2835 In Vitro & In Vivo Diagnostic Substances